Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EndoTic: Ticagrelor vs Clopidogrel in ACS
NCT02244710Completed
- Sponsor
- Fundación de Investigación Sanitaria de León
- Start
- Mar 2015
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of ticagrelor in acute coronary syndrome (ACS) (2 arms), sponsored by Fundación de Investigación Sanitaria de León. Primary endpoints: Number of Circulating Endothelial Cells at 1 month and Number of Endothelial Progenitor Cells at 1 month. Started Mar 2015; status: completed.
02
Drugs
ticagrelor
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT02244710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02244710.